With the rapidly-expanding sophistication in our understanding of cancer cell biology, molecular imaging offers a critical bridge to oncology. Molecular imaging through magnetic resonance spectroscopy (MRS) can provide information about many metabolites at the same time. Since MRS entails no ionizing radiation, repeated monitoring, including screening can be performed. However, MRS via the fast Fourier transform (FFT) has poor resolution and signal-to-noise ratio (SNR). Moreover, subjective and non-unique (ambiguous) fittings of FFT spectra cannot provide reliable quantification of clinical usefulness. In sharp contrast, objective and unique (unambiguous) signal processing by the fast Padé transform (FPT) can increase resolution and retrieve the true quantitative metabolic information. To illustrate, we apply the FPT to in vitro MRS data as encoded from malignant ovarian cyst fluid and perform detailed analysis. This problem area is particularly in need of timely diagnostics by more advanced modalities, such as high-resolution MRS, since conventional methods usually detect ovarian cancers at late stages with poor prognosis, whereas at an early stage the prognosis is excellent. The reliability and robustness of the FPT is assessed for time signals contaminated with varying noise levels. In the presence of higher background noise, all physical metabolites were unequivocally identified and their concentrations precisely extracted, using small fractions of the total signal length. Via the "signal-noise separation" concept alongside the "stability test", all non-physical information was binned, such that fully denoised spectra were generated. These results imply that a reformulation of data acquisition is needed, as guided by the FPT in MRS, since a small number of short transient time signals can provide high resolution and good SNR. This would enhance the diagnostic accuracy of MRS and shorten examination times, thereby improving efficiency and costeffectiveness of this high throughput cancer diagnostic modality. Such advantages could be particularly important for more effective ovarian cancer detection, as well as more broadly for improved diagnostics and treatment within oncology.
Introduction
As an emerging medical discipline, molecular imaging brings together molecular biology and diagnostic imaging. Vital information can potentially be obtained for early cancer detection as well as regarding progression, prediction of response to therapy and assessment of actual treatment efficacy. With our rapidly expanding knowledge of the cell biology of cancer, molecular imaging is of key importance for clinical oncology.
Molecular versus Anatomic Imaging
Anatomic or morphologic imaging is also essential for cancer detection, as well as for staging and evaluation of response to therapy. Anatomic modalities, particularly magnetic resonance imaging (MRI) are generally sensitive, such that cancerous lesions can very often be identified. The most critical limitation of purely anatomic imaging is insufficient specificity, meaning that many non-malignant lesions will be detected, with the need for further investigation (including invasive procedures such as biopsy) to distinguish them from cancers. The potential deleterious consequences of false positive findings include unnecessary workup, expense and adverse psychological effects. These can lead to lowered adherence to medical recommendations, including surveillance post-therapeutically and among persons at high cancer risk (1) .
Combined Diagnostic Modalities: Complementarity of PET-CT and MRSI
Molecular imaging enhances specificity compared to anatomic imaging alone. Currently, positron emission tomography (PET) is the molecular imaging modality most widely applied in clinical practice within oncology. Whole-body PET-CT (computerized tomography) is demonstrated to improve cancer staging compared to anatomical imaging alone. In up to 40% of cases, PET-CT leads to changes in therapeutic management of patients with cancer (2) (3) (4) . Notwithstanding the advances of molecular imaging with PET-CT, there are limitations especially related to lack of specificity of individual radiotracers for distinguishing cancerous from non-cancerous pathology (2) (3) (4) (5) .
Combined molecular and anatomic imaging can also be achieved by MRS together with MRI to yield MRSI. Magnetic resonance (MR)-based modalities have several advantages compared to PET-CT. Among these is lack of exposure to ionizing radiation, especially important when repeated monitoring is needed, including for persons at increased cancer risk. A potential advantage of MRS/MRSI is improved distinction between cancerous and non-malignant pathology, since information could be provided about the concentration of a larger number of metabolites at the same time, whereas most applications of PET are limited to a single radiotracer. Current disadvantages of MR-based modalities include high expense and long examination time of the patient. Importantly, PET-CT and MRS/MRSI are complementary in their advantages that are whole body scans and localized diagnostics for the former and latter, respectively. Overall, MRS/MRSI are viewed by leading experts as a modality which could revolutionize not only cancer diagnostics, but also molecular-image guided surgery and biopsy, as well as target delineation for radiotherapy (6) (7) (8) (9) (10) (11) (12) (13) (14) . However, robust and more reliable signal processing within MRS/ MRSI than that in the past and current practice is crucial for achieving this potential, as emphasized by e.g. the U.S. National Cancer Institute (6) . In this paper, we address these challenges and the overall potential of MRS/MRSI with suggested practical solutions.
Why does Progress in MRS/MRSI for Oncology Depend Critically upon Mathematical Optimization?
Excited tissue slices scanned by MRS and MRSI produce time signals or free induction decay (FID) curves. Mathematical methods are needed since the measured i.e. encoded time signals are not of direct use. This is the case because FIDs are tightly-packed, damped oscillations with no discernible pattern amenable to interpretation. The time signals need to be mapped into the frequency domain which yields the spectrum with a relatively smaller number of potentially discernible structures such as peaks, called resonances, that represent various metabolites. Metabolites are molecules that may be critical to functions on vastly different levels, ranging from cells through tissues to the entire organ. The peak positions, widths, heights and phases are the spectral parameters that determine the resonant frequencies, relaxation times and concentrations of metabolites in the scanned tissue.
These parameters are obtained by quantification, which is an inverse problem, also known as spectral analysis. Here, the measured result (the time signal) is known, but its constituent elements (the spectral parameters) need to be found. Inverse problems are present throughout medicine via the relationship between the "known effect(s)" and "the unknown cause(s)" (15, 16) . In both MRS and MRSI, metabolite resonance frequencies and amplitudes of signals are of critical importance from the biochemical and clinical standpoints. Fundamental frequencies inform about electronic shielding and the environment of the resonating nuclei bound to various molecules of the tissue. Amplitudes provide information about the number of resonating nuclei and, therefore, are proportional to metabolite concentrations. Signals from MRS and MRSI can be spectrally analyzed by the same processor. The only Technology in Cancer Research & Treatment 2013 December 17. Epub ahead of print difference is that FIDs from MRS and MRSI are encoded in single and multi-voxels, respectively. Since multiple voxels cover the whole examined volume, MRSI is clinically important whenever it is deemed that MRS is insufficiently representative for the entire scanned tissue.
The Fast Fourier Transform, the FFT
The FFT can obtain only the total shape spectrum (envelope) through non-parametric estimation. The FFT spectrum can be computed only at the pre-assigned Fourier grid points. This implies that the FFT has no interpolation or extrapolation features. Because of its simplicity and speedy computation, the FFT is built into every MR scanner and, as such, is conventionally used to generate the frequency spectrum from the averaged time signal. To improve signal-to-noise ratio (SNR), the FFT employs this averaged time signal from typically about 200 encoded FIDs. The computed FFT spectrum necessitates a long signal acquisition window to yield the needed frequency resolution. Herein lies the inefficiency of the FFT: it is precisely the combination of long readout length for each encoded time signal and multiple FID acquisitions plus averaging that result in long examination times, one of the main reasons for the high cost of the MR procedure.
In addition to its low resolution and SNR, the FFT itself is not capable of providing quantification, which is the principal task of MRS. In order to estimate metabolite concentrations from an FFT spectrum, fitting techniques are employed. All fitting models in MRS with their unavoidable non-uniqueness as a major drawback require surmising the number of components underlying each peak. Such guesses cause severe ambiguities as they inevitably generate false information (overfitting, overmodeling) or fail to detect true metabolites (underfitting, undermodeling) . Either situation presents new dilemmas and is, therefore, very troublesome for clinicians. Non-uniqueness means that the results of quantification change for any alteration of e.g. the starting guesses of the spectral parameters, fitting constraints such as prior knowledge, fixed ratios of some peak heights, etc.
The Fast Padé Transform, the FPT
The above-enumerated defects of the FFT are surmounted by the FPT, through more comprehensive and robust mathematics. A spectrum in the FPT is expressed as a ratio of two frequency-dependent polynomials P K /Q K extracted uniquely and directly from the raw (unedited) MRS time signal. By comparison, the FFT gives a spectrum through a single polynomial F N of degree equal to the full signal length N. The total shape spectrum P K /Q K in the FPT is obtained at any frequency. Here, degree K  N/2 is the number of resonances. Hence, the FPT has interpolation capability. Moreover, the FPT possesses extrapolation capacity, as well (15) (16) (17) (18) . These two features provide high-resolution and improved SNR, and thereby open the way towards a reformulation of the approach to data acquisition, as will be discussed later in this paper.
In quantification of MRS data, it is vital to incorporate the structure of every particular time signal under study. The FFT fails in this regard since it can compute the spectrum only at fixed Fourier grid points that are the same for all FIDs of the same length. By contrast, the FPT takes into account the structure of each time signal from the outset by referring to its intrinsic features of oscillations such as nodal frequencies and amplitudes. Precisely these two different approaches toward the internal structure of the investigated time signals categorize the FPT and the FFT as parametric and non-parametric processors, respectively.
As a parametric estimator, the FPT reconstructs the exact number K of resonances and their 2K genuine parameters (complex frequencies and complex amplitudes). Of course, a single metabolite can have more than one resonance. Through signal-noise separation (SNS) (17) (18) (19) , quantification and disentangling physical signal from noise are solved simultaneously. Robust error analysis is performed by searching for constancy of the retrieved spectral parameters and resulting stability of component and total shape spectra. Cross-check/validation is provided by two conceptually different, but mathematically equivalent variants of the FPT that work inside (causal, FPT (1) ) and outside (anticausal, FPT (2) ) the unit circle in the complex frequency plane (15) (16) (17) (18) . When these two variants converge, the ensuing spectral parameters are binned as belonging to physical, stable resonances. Non-converged resonances are unstable such that they are classified as unphysical (spurious or pseudo-resonances) and discarded because of their noise-like or noisy content. This binning via "stability versus instability grouping" accomplishes SNS, after which the output data necessarily contains only the true information. This completes the process of unequivocal quantification of MRS data by the FPT in both variants, FPT (1) and FPT (2) . Some brief highlights concerning the theoretical basis of the FPT are as follows. The functions describing any time signal {c n } and the corresponding spectrum emerge uniquely from quantum dynamics of generic investigated systems (15) . This is the case because signal processing is part of a larger framework-the fundamental physics theory, quantum mechanics, where it has been established (15) that the complete mathematical model of the frequency spectrum for a given time signal is prescribed by the unique ratio of two polynomials, which is identified as the FPT. In the time domain, quantum mechanics predicts the form of the FID, {c n }, by a sum of the attenuated natural vibrations or oscillations described with the damped complex exponentials in the time evolution operator of a general system, as is also the case in the FPT. Such forced oscillations are attenuated because of the finite duration of the associated metastable state. As a consequence, an emission structure in the spectrum is not a zero-width lineshape with the corresponding infinite lifetime of a stable state. Rather, it is a broadened structure appearing as a peak of non-zero width which implies a limited, finite lifetime of the underlying unstable state, prone to decay. Physically, a finite peak width in a spectrum means that a perturbed state responds to an interval of externally imparted frequencies rather than to a single frequency exerted onto the system. By virtue of the time-frequency dual representation, the same physics automatically prescribes that the frequency spectrum is given by the unique quotient of two polynomials, as done by the FPT, as well. These features constitute the true origin of the subsequently confirmed algorithmic success of the FPT, via its highly accurate reconstructions, even to machine accuracy for benchmarked synthetic time signals (15) (16) (17) (18) . These considerations have justified the application of the FPT in the clinical setting of MRS, especially when it comes to the sought reliability of diagnostically relevant information extracted from the scanned tissue.
For non-parametric estimation of total shape spectra, the FPT is a fast processor. By the Euclid algorithm, the FPT is computationally almost as efficient as the FFT (15) with N(log 2 N) 2 versus Nlog 2 N multiplications for the former relative to the latter processor. Of course, extra effort is required for parametric estimation, which necessitates quantification of spectra to reconstruct the hidden metabolite content of the scanned tissue. Nevertheless, also in this case, computations in the FPT are extremely fast because of quick rooting of the polynomials by means of the equivalent diagonalization of the extraordinarily sparse Hessenberg (or companion) matrix (15) . For exceedingly long time signals, additional saving of computational time is possible by vectorizing the algorithms in the FPT, alongside parallel processing of the only two operations (solving a system of linear equations and finding the zeros of polynomials P K and Q K ). Even without vectorization and processing on parallel computers, the entire work on quantification takes only a few minutes for signal lengths of 1024 or 2048 data points. Precisely such signals are typically encoded in MRS and MRSI.
As to the availability of computer software for the FPT, the most user-friendly possibility is to directly apply Matlab, IMSL or Numrec libraries (15) . These libraries have built-in codes for (i) solving systems of linear equations to obtain the expansion coefficients of Q K and (ii) polynomial rooting for quantification. Moreover, for the given sum the same computational libraries provide codes for direct generation of total shape spectra P K21 (z 21 )/Q K (z 21 ) or P K (z 21 )/Q K (z 21 ) in the paradiagonal and diagonal FPT, respectively.
MRS/MRSI for Cancer Diagnostics Focusing on Applications of the FPT
We shall discuss four problem areas of major public health concern: brain tumors, prostate, breast and ovarian cancers. The focus is on the role of two different approaches to data analyses, the FPT and the FFT, in tackling these problems.
Ovarian Cancer
Effective methods for early detection of ovarian cancer are still lacking. These are urgently needed to improve survival from this malignancy (16, 20, 21) . Due to the small size of the ovary and its motion within the pelvic cavity, conventional Fourier-based applications of in vivo MRS for ovarian cancer detection have been hampered by limited resolution and the transfer of unaltered noise from the time domain to the frequency domain, leading to poor SNR (16, 20) . The latter limitation of the FFT stems from its linearity. On the other hand, malignant ovarian lesions can be quite well distinguished from benign adnexal changes via in vitro MRS at strong magnetic fields with high resolution capabilities. For example, the concentrations of very closely-lying resonances such as isoleucine (Iso) at 1.02 parts per million (ppm) and valine (Val) at 1.04 ppm are thereby found to significantly differ in these two types of ovarian lesions (22) . These amino acids are protein breakdown products due to necrosis and proteolysis.
In applications to time signals associated with MRS data for benign and malignant ovarian cyst fluid from Ref. (22) , the FPT has been shown to accurately reconstruct the spectral parameters for all the physical metabolites, including those that were very closely lying, by using only small fractions of the full time signal (16, 23, 24) . In direct comparison, the FFT produced completely uninterpretable spectra at these short signal lengths (16, 23) . The results from earlier studies (16, 23, 24) have illustrated the clear superiority of the FPT compared to the FFT, in improving SNR and resolution, as well as in the initial findings related to separating noise from signal for the ovary data.
Breast Cancer
The diagnostic accuracy of MRI, especially specificity for breast cancer detection can be substantially enhanced by in vivo MRS, based upon data published for more than 200 breast lesions (16, (25) (26) (27) . In these publications, postprocessing of the FFT by fitting was used, with attendant problems in resolution and SNR, as well as non-uniqueness. Moreover, estimates were restricted mainly to a single composite compound, total choline (tCho). The limitations of this approach are most notable for distinguishing smaller malignant tumors from benign breast lesions (28) , since tCho may not be detected in small tumors that are then misclassified as benign (25) . On the other hand, tCho can also be found in benign breast pathology as well as during lactation (25) . In vitro MRS reveals that rich spectroscopic information in very closely-overlapping resonances can better identify breast cancer (29) . In applications to these in vitro MRS data from normal, benign and cancerous breast, as encoded in Ref. (29) , the FPT was shown to accurately reconstruct all the physical metabolites, even those that were completely overlapped: phosphocholine and phosphoethanolamine at 3.22 ppm (16, 30, 31) . This is particularly important since phosphocholine is a reported marker of malignant transformation (7, 32) .
Prostate Cancer
In vivo MRS/MRSI have also improved many aspects of prostate cancer diagnostics/decision-making compared to MRI alone. These include distinction from benign prostatic hypertrophy, guidance in selecting biopsy site(s), detecting the dominant intra-prostatic lesion for a boost dose of radiation as well as for detecting extracapsular extension in tumor recurrence after therapy (9, 12, 16, 33, 34) .
With Fourier-based processing, however, limitations in MRS/MRSI are manifested in e.g. inadequate sensitivity for analyzing smaller lesions, distinguishing high-versus lowrisk malignancies, and the lack of clear interpretation of posttherapeutic spectral changes in various settings. In vitro MR spectra of the prostate are very dense, with abundant multiplet resonances that are exceedingly difficult to assess and unambiguously quantify. In applications to such in vitro data associated with encoding from normal and malignant prostate (35) , the FPT resolved and precisely quantified all physical resonances, including multiplet spectral structures as well as overlapping peaks of different metabolites, and thereby generated the metabolite concentrations which distinguish normal from malignant prostate (16, 33, 36) .
Neuro-oncology
It is within neuro-oncology that MRS/MRSI have been most widely applied and their potential best appreciated, as reviewed in e.g. Refs. (8, 11, 12, 37, 38) . Viewed in that light, the limitations of the FFT become all the more striking. Namely, within the FFT neuro-diagnostics through MRS/MRSI have often been reduced to semi-quantitative approaches based upon a very small number of metabolites and/or their ratios. Within radiation neuro-oncology, our recent meta-analysis (39) revealed that by using metabolite ratios, a substantial percentage of recurrent primary brain tumors and radiation necrosis were misclassified. The FPT applied to in vitro MRS time signals encoded from normal human brain achieves markedly superior resolution compared to the FFT, and can identify and precisely quantify at least 25 metabolites (16) (17) (18) 40) . It is thus suggested that Padé-optimized MRS/MRSI holds particular promise for neuro-oncology.
The outlined applications of the FPT (15-19, 23, 24, 30, 31, 33, 36, 37, 39, 40) illustrate the capabilities of this more advanced approach to signal processing for improving MRS-based cancer diagnostics. In this paper, we present some strategic new steps by which the FPT improves resolution in the presence of much higher noise levels than those in previous investigations (16, 24) . These steps are amply illustrated in the present work in direct relation to ovarian cancer diagnostics, given the urgent clinical need for improved early detection of this malignancy.
Materials and Methods
The present analysis is performed using MRS time signals {c n } given by a linear combination of damped complex harmonics of the following mathematical form:
where N is the total signal length and τ is the sampling time.
The nodal (natural) or fundamental complex frequencies and complex amplitudes are represented by the quantities {ω k } and {d k }, respectively. It is by way of Eq.
[1] that the particular structure of each studied FID is invoked in signal processing by the FPT.
The mathematical model of the frequency spectrum for this MRS time signal is prescribed by the unique ratio of two polynomials, which, by definition, is the FPT. This polynomial quotient P K /Q K (diagonal) or P K21 /Q K (para-diagonal) from the FPT is a rational function in the harmonic variable z 21 5 exp(2iωτ). The FPT performs parametric quantification by rooting the polynomial Q K whose roots
. This leads to the amplitudes d k (1  k  K ) for K resonances in a non-degenerate spectrum. The non-degenerate version of the para-diagonal FPT, which is the FPT (2) , approximates the exact finite-rank spectrum G N (z 21 ), via the unique ratio of two polynomials, 
where {p r , q s } are the expansion coefficients. Coefficients {p r , q s } of polynomials P K21 and Q K are computed via the unique solution of a single system of linear equations, treating G N Q K as a convolution:
1 . Similar computations yield P K and Q K for the diagonal form
is the complex-valued total shape spectrum (envelope). This is the sum of precisely K corresponding component spectra
The expounded algorithm is systematically benchmarked by the general Padé polynomials P K and Q K for any integer K  0 in terms of the existing analytical expressions (15) . These closed formulae for P K and Q K are given exclusively through the analytically available expansion coefficients of the so-called contracted continued fractions (CCF). Importantly, these CCFs contain both the FPT (1) and FPT (2) . This follows from the fact that the even or the odd order of the CCF coincides with the Padé (15, 19) .
An absorption spectrum is the real part of a complex-valued spectrum. The FPT has interpolation features because frequency ω in harmonic variable z 21 is arbitrary and not just on the Fourier grid.
Moreover, the ratio P K21 (z 21 )/Q K (z 21 ) in the FPT is implicitly an infinite sum because the reciprocal of the denominator polynomial Q K (z 21 ) is a series. Such a circumstance gives an approximate extension of the input finite sum
beyond N. This constitutes the extrapolation feature of the FPT. Extrapolation means prediction. Hence, the FPT has predictive power.
In comparison, the FFT is given by:
where 2π k/T are fixed Fourier grid frequencies that are unrelated to ω k from c n . Here, T is the total duration or acquisition time of the signal, T 5 Nτ. As mentioned, in the FFT, any two different time signals c n of the same length N are computed at the identical frequencies 2π k/T that yield the Fourier stick spectra. This is how the specific structure of the given FID is overlooked in the FFT.
To extract the peak parameters, we solve characteristic equation Q K (z 21 ) 5 0 which has exactly K unique roots − z k 1 (1  k  K) and then, the sought k th fundamental frequency ω k is deduced via ω k 5 (i/τ) ln( − z k 1 ), as stated. The corresponding expressions for the diagonal spectrum P K /Q K in the FPT can be found in e.g. Ref. (15) . Thus, in the diagonal FPT, non-degenerate amplitude d k is given by
Here, the notion "non-degenerate" means that for each ω k there is only a single d k . The FPT can also give a degenerate spectrum where two or more amplitudes correspond to the same frequency (15) .
The exact number K of true metabolites is found by the denoising Froissart filter (DFF), which disentangles the genuine from spurious resonances. The DFF separates the retrieved spectral parameters of: (a) spurious (unstable) resonances -for which spurious poles from Q K 5 0 coincide or nearly coincide with spurious zeros from P K 5 0 (pole-zero cancellations or Froissart doublets in P K /Q K ) and (b) genuine (stable) resonancesfor which poles and zeros of the Padé spectrum P K /Q K differ from each other. The difference between the total number of reconstructed metabolites and Froissart doublets gives K as the number of genuine metabolites. Amplitude d k is proportional to the distance between the roots of the numerator and denominator polynomials in the FPT. Genuine and spurious resonances have d k  0 and d k  0, respectively. Zero or near zero amplitudes represent yet another signature of unphysical resonances.
Error analysis based on the test of stability of all the reconstructed parameters as well as on constancy of the resulting spectral shapes in the whole Nyquist range enables an unequivocal separation of the true from the false information in the analyzed data. Through the FPT and the denoising Froissart filter, we use the mentioned procedure of "binning" whereby a denoised spectrum is generated, displaying exclusively the recognized genuine metabolites, while the unstable resonances are unequivocally identified and discarded.
The FPT quantifies by extracting the parameters of all the physical metabolites using only the original raw (unedited) time signal. This is the origin of the objectivity of the FPT. Peak positions or chemical shifts are equal to Re(ω k ), peak widths are proportional to Im(ω k ) and peak heights are proportional to |d k |/Im(ω k ). Hereafter, the symbols Re and Im denote the real and imaginary part of the complex number, respectively. The area underneath each resonance is proportional to |d k |. This is directly related to the relative concentration of the k th metabolite. Absolute concentration is obtained by using a reference concentration of e.g. water or a chemical substance such as trimethylsilyl-tetradeutero-propionic acid, not present in the tissue. 
The Input Data
Our analysis is based upon MRS time signals encoded in Ref. (22) , where twelve metabolites were estimated in the frequency range from 1.0 to 6.0 ppm. Thus, we set K 5 12. We derived the input data for the spectral parameters {ω k } and {d k } according to the values reported in Ref. (22) . Moreover, all the phases from the complex amplitudes d k are set to zero. Thereby, each amplitude d k is defined here as being real, d k 5 |d k |. The linewidths were estimated in Ref. (22) 
for the 12 metabolites are used herein. The input data for the present study with the spectral parameters, the peak assignments and metabolite concentrations are presented in Table I .
Addition of Noise
Besides the noise-free case, we also quantify the noisecorrupted input data. To this end, we add complex-valued random zero-mean Gauss-distributed white noise of a prescribed level to the noiseless MRS time signal. The selected noise levels herein are σ 5 0.01156, 0.1156, 0.1296 and 0.2890 RMS, where RMS is the root-mean-square of the noise-free time signal,
We use RMS because it simultaneously minimizes two measures, the bias relative to the actual (sought) value and the variance of noise. Moreover, RMS is a measure of the dynamics of the signal, since it converts signal oscillations to variations of the power of the signal across the given bandwidth.
Fourier Reconstruction of the Absorption Total Shape Spectra
In Ref. (22) , the time signals were recorded with a static magnetic field strength B 0 5 14.1 T (the corresponding Larmor frequency is v L 5 600 MHz) and bandwidth of 6667 Hz. The reciprocal of the bandwidth is the sampling time τ. In Ref. (22) , the total signal length N was chosen in accordance with the resolving power Δω min 5 2π/T of the FFT. The Fourier spectral resolution would thereby be 0.02 ppm, as needed to split apart the two most tightly-spaced metabolites isoleucine and valine, whose chemical shifts differ by 0.019 ppm. Consequently, the closest integer in the form 2 m for the time signal length required by the FFT would be N 5 2 15 5 32768 (32 KB, 1 KB 5 1024 bytes of data, i.e. signal points). This is the signal length from the encoding in Ref. (22) .
Reconstruction of the Absorption Total Shape Spectra via the FPT
Since the resolution in the FPT is not limited by the Fourier grid, substantially shorter time signals {c n } can be employed compared to those used in Ref. (22) . Herein, we sampled the time signals with τ 5 1/(6667 Hz) and N 5 1024 (1 KB), Table I  Input i.e. some formidable 32 times shorter than the time signal from Ref. (22) . Under these circumstances, it follows that RMS 5 1.6472. Cross-checking has been performed of all the reconstructions using the two complementary forms, FPT (2) and FPT (1) . In the analysis reported in this paper, we present only the results from the FPT (2) in the diagonal
for the complex Padé spectrum. The absorption total shape spectra are generated from the spectral parameters reconstructed by the FPT.
Results

Resolution of Total Shape Spectra for Ovarian Cancer MRS-data via Fourier and Padé Processing
We begin by comparing the resolution performance of the FPT and FFT for MRS data from malignant ovarian cyst fluid in the noiseless case. The FPT accurately reconstructed all the spectral parameters from which concentrations were correctly computed for all 12 metabolites with only 64 signal points out of 1024 sampled data. Convergence remained completely stable for all longer partial signal lengths, as well as at the full signal length. In contradistinction, with 64 signal points, the FFT yielded rough, completely uninformative spectra. These results are illustrated in Figure 1 , in which the Fourier and Padé-processed absorption total shape spectra are shown on the left and right panels, respectively, at partial signal lengths, N P 5 256, 128 and 64 data points.
Computation in the FFT using FIDs of much longer lengths, 8 KB and 16 KB, i.e. those with 8192 and 16384 signal points has not converged since it yielded several incorrect peak heights alongside significant baseline distortions. The first positivedefinite absorption spectrum in the FFT is obtained employing N 5 8 KB 5 8192 bytes, whereas the first convergence of the Fourier spectra is attained at N 5 32 KB, i.e. 32768 signal points. This coheres with the general experience that a comparable resolution of the FFT and FPT for estimation of the total shape spectra can be reached only for much longer signal lengths using the former processer. Conversely, for the same signal length, the FPT has much better resolution than the FFT. In the case of the FID considered in Figure 1 , the FFT would need some astounding 512 times longer signal to achieve the resolution of the FPT for the spectral envelope (23, 24) . Moreover, even if the FFT could converge for shorter FIDs, it would still be unable to provide quantification on its own.
Separation of Genuine from Spurious Resonances for Ovarian Cancer Data by the FPT
Froissart Doublets: Pole-zero Coincidence with Marked Instability: In Figure 2 , we compare the FPT-based reconstructions with the noiseless and noisy (σ 5 0.01156 RMS) input data in a part of the Nyquist interval from 1.4 ppm to 6.2 ppm at a partial signal length N P 5 N/8 5 128. The so-called Argand plots (the real versus imaginary parts of a complex quantity) for noise-corrupted and noise-free input data are displayed in panels (i) and (ii), respectively. The reconstructed absolute values of the amplitudes for the noisy time signal are presented in panel (iii). In each of these three panels (i) to (iii), the exact noiseless input parameters are displayed, as well. Thus, it is shown that the FPT exactly reconstructed the input parameters, both in the noiseless case (panel ii) and in the presence of noise (panels (i) and (iii) with the corruption level σ 5 0.01156 RMS). This, in itself, illustrates the capacity of the FPT to achieve optimal reduction of noise.
In panels (i) and (ii) of Figure 2 The only perceivable difference between these two panels (i) and (ii), i.e. with and without added noise, is that in the former these Froissart doublets are quite irregularly arrayed whereas in the latter they appear rather like a well-aligned chain. The irregular arrangement or pole-zero distribution stems from the added noise.
In panel (iii) of Figure 2 , the zero-valued absolute ampli-
, corresponding to the pole-zero confluences can be seen. As a visual aid, we drew a horizontal line at the zero value of the ordinate, so that it could be readily appreciated that (22) . In this and all subsequent figures, the abscissa displays chemical shifts, as dimensionless linear frequencies v, in parts per million (ppm), where v 5 ω/(2π) and ω is the angular frequency. Herein, the ordinates are the real parts of complex-valued spectra in arbitrary units (au) and v L is the Larmor frequency. Via the FPT, the total absorption shape spectrum converges at N P 5 N/16 5 64 signal points (panel (vi)), yielding twelve metabolites, whose acronyms are given in Table I . Total signal length is N 5 1024. As illustrated in panels (iv) and (v) at N P 5 256 and 128, respectively, this convergence is stable for longer signal lengths. In sharp contrast, the fast Fourier transform, or FFT, generates rough and completely uninformative spectra at the same three partial signal lengths N P . These three Fourier spectra at N P 5 N/4 5 256 (panel (i)), N P 5 N/ 8 5 128 (panel (ii) ) and N P 5 N/16 5 64 (panel (iii)) differ substantially from each other, especially in that the prominent peak at frequency 1.5 ppm is wider with a much smaller amplitude at the shorter partial signal lengths N P 5 N/8 5 128 and N P 5 N/ 16 Figure 3 . For both noise levels, the FPT exactly reconstructed all the noiseless input parameters. On the Argand plot shown in panel (i) at the ten times higher noise level σ 5 0.1156 RMS, the spurious resonances show an even more irregular distribution. Furthermore, pole-zero coincidence is often either lacking or not exact. Concordant with this observation is that on panel (iii) a few of the spurious amplitudes are non-zero. Notably, at 5.8 ppm the height of the spurious resonance and that of choline at 3.2 are quite similar.
The latter findings just mentioned and illustrated in Figure 3 with a higher noise level raise a critical question: how can one be certain which of the resonances are spurious and which are genuine? A clear answer to this dilemma is indispensable, particularly for proceeding from these controlled input data to encoded time signals for which the genuine spectral parameters are, of course, not known prior to quantification. A reliable way to distinguish the true from spurious peaks is vitally needed.
The "Envelope Stability Test"
In order to answer this query, we present the "envelope stability test", as illustrated in the next four figures. We begin in Figure 4 by examining the absorption total shape spectra at the same noise level σ 5 0.1156 RMS, but with two different partial signal lengths (N P 5 930, 950) in panels (i) and (ii), respectively. It is at once apparent that all the 12 physical resonances are the same as those reconstructed by the FPT for the noiseless case. In other words, these genuine resonances are stable even with the presence of higher noise levels and remain so at different partial signal lengths. In sharp contrast, even with a slight change in the partial signal length consisting of an additional 20 data points, it is clear by comparing panels (i) and (ii) that the other spectral structures appearing along the background vary substantially. This is one facet of the envelope stability test, which allows the initial distinction between genuine and spurious resonances prior to inspecting the tabular form for the output list of quantification.
Another way to perform the envelope stability test is to also vary the noise level. In Figure 5 , we present the Padé-reconstructed absorption total shape spectra with a noise level of σ 5 0.1156 RMS and σ 5 0.2890 RMS in panels (i) and (ii), respectively. Notwithstanding a considerable difference in noise level (a factor of 2.5), the 12 genuine resonances are identically and correctly reconstructed by the FPT. The other spectral structures differ notably, as can be appreciated by comparing panels (i) and (ii) of Figure 5 . Hence, the latter unstable structures can be categorized as spurious.
Thus far, we have illustrated how error analysis can be performed based on a test of stability of the reconstructed parameters as well as on the constancy of the resulting spectral shapes in the envelope spectra. This is done for the entire Nyquist range (to avoid clutter, only a part of which was illustrated in these figures) together with the accompanying analysis of the corresponding numerical values. The result is SNS, namely the clear distinction between the genuine and spurious information obtained in the Padéreconstructed data. The next step is to perform binning, whereby only the physical, i.e. stable spectral structures are retained.
In Figure 6 , the denoising procedure is illustrated for the noise level σ 5 0.1156 RMS, at two different signal lengths N P 5 950 (upper panels) and N P 5 930 (lower panels). The genuine spectral structures are unambiguously identified and as seen in the right panels (iii) and (iv) of Figure 6 , in which the "denoised" spectra are generated. Most importantly, these can be evaluated with full confidence. To confirm this statement, one can make a side-by-side inspection of the denoised spectra, displayed in panels (iii) and (iv) from Figure 6 and panels (iii) or (iv) from Figure 1 which depict the converged absorption total shape spectra for the noiseless case.
In the presence of 2.5 times higher levels of background noise than in Figure 6 , namely σ 5 0.2890 RMS, the genuine spectral structures are still unambiguously identified. As seen in panel (ii) of Figure 7 , the "denoised" spectrum is generated, including the exactly reconstructed chemical shifts and all the correct metabolite concentrations. Tables II and III show the numerical results of Padéreconstruction in the presence of background noise σ 5 0.1296 RMS at two different partial signal lengths, N P 5 750 and N P 5 850. It is seen in both these tables that all the genuine metabolites are exactly identified and their spectral parameters and concentrations are fully correct. Altogether 363 and 413 spurious resonances were generated at N P 5 750 and N P 5 850, respectively. Due to their instability, these are all binned as unphysical and, as such, filtered out with certainty from the complete output list of the reconstructed data. This is the essence of SNS, as accomplished by the denoising Froissart filter, or DFF. In Tables II and III Tables II and III the spectral parameters and concentrations are displayed for a total of 25 and 28 spurious resonances, respectively. In comparing these two tables, the instability of these unphysical resonances is readily apparent, with respect to their positions, relaxation times, amplitudes and computed concentrations. In particular, The envelope stability test is carried out for two unequal higher noise levels and two different partial signal lengths. Padé-based reconstruction of spectral frequencies and absolute values of amplitudes for a time signal synthesized in accordance with that encoded from ovarian cancer cyst data at B 0  14.1 T (Larmor frequency, v L 5 600 MHz) from Ref. (22) . To the noiseless time signal, the complex-valued zero-mean random Gaussian-distributed noise of levels σ 5 0.1156 RMS and σ 5 0.2890 RMS is added on panels (i) and (ii), respectively, where RMS is root-mean-square of the noise-free time signal. The number of signal points employed for these two noise levels was, respectively, N P 5 930 and N P 5 740 out of N 5 1024, which is the total length of the sampled MRS time signal.
Numerical Illustration of the Binning Procedure
Figure 6:
Noise is eliminated from the noise-corrupted total shape spectrum via the "denoising" procedure. Padé-based reconstruction of spectral frequencies and absolute values of amplitudes for a time signal synthesized in accordance with that encoded from ovarian cancer cyst data at B 0  14.1 T (Larmor frequency, v L 5 600 MHz) from Ref. (22) . To the noiseless time signal, the complex-valued zero-mean random Gaussian-distributed noise of level σ 5 0.1156 is added at two different signal lengths N P 5 950 (upper left panel (i)) and N P 5 930 (lower left panel (ii)), where N 5 1024 is the total length of the sampled MRS time signal. The "denoised" spectra at these two signal lengths are shown in the right panels (iii) and (iv). This is obtained by a binning procedure within the concept of SNS, whereby the stable resonances are retained from the noisy output data and the unstable resonances are discarded via the denoising Froissart filter, or DFF. Figure 7 : A higher noise level is eliminated from the noise-corrupted total shape spectrum via the "denoising" procedure. Padé-based reconstruction of spectral frequencies and absolute values of amplitudes for a time signal synthesized in accordance with that encoded from ovarian cancer cyst data at B 0  14.1 T (Larmor frequency, v L 5 600 MHz) from Ref. (22) . The number of signal points employed is N P 5 740 out of N 5 1024 which is the total length of the sampled MRS time signal. To the noiseless time signal, the complex-valued zero-mean random Gaussian-distributed noise of level σ 5 0.2890 RMS is added on panel (i), where RMS is root-mean-square of the noise-free MRS time signal. The denoised spectrum is shown in panel (ii). It is obtained by a binning procedure within the concept of SNS, whereby the stable resonances are retained from the noisy output data and the unstable resonances are discarded via the denoising Froissart filter, or DFF. This figure is deemed to be of particular clinical usefulness due to its comprehensiveness, as it juxtaposes, in the form of graphs, both the quantification output and spectral shapes before and after "denoising", with no loss of true physical information.
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the pattern in which these spurious resonances are interspersed between the genuine metabolites differs markedly at these two partial signal lengths. Thus, the numerical procedure by which binning is performed is illustrated herein.
This binning within the output list of reconstructions as achieved by the concept of SNS and its implementation by DFF, is the essence of automatic classification of metabolites according to the main concern of MRS -the nature (true or false) of the information. In applications of the FPT to MRS data, an alternative procedure has been applied for automatic classification of quantified metabolites using the conditional probability to statistically validate the estimated parameters (41) .
Table II
Padé-based reconstruction of spectral parameters and concentrations of metabolites using a noise-corrupted time signal reminiscent of the in vitro MRS time signal encoded in Ref. (22) at B 0  14.1 T (Larmor frequency, v L 5 600 MHz) from cancerous ovarian cyst fluid. Complex-valued zero-mean random Gaussian-distributed noise of level σ 5 0.1296 RMS is used to contaminate the noiseless time signal. Here, RMS is root-mean-square of the noisefree time signal, which is built from the input parameters given in Table I . Partial signal length employed is N P 5 750, where N is the total length of the time signal (N 5 1024). Altogether 363 spurious resonances were generated in the entire Nyquist interval. Using a cut-off value d | | k −  0.001 for retaining the retrieved resonances, 25 spurious resonances are seen in the displayed frequency range. The presently performed analysis shows that convergence in quantification by the FPT necessitates a larger degree K of Padé polynomials P K and Q K for higher noise levels. This is needed to accurately and robustly undo the higher perturbation effect on the input data by increased contamination via the added noise.
Discussion with General Repercussions for MRS
The presented results illustrate how an MRS time signal can be accurately and reliably processed in the presence of background noise. This strategy utilizes the high resolution capability and robustness of the FPT through the SNS, Table III Padé-based reconstruction of spectral parameters and concentrations of metabolites using a noise-corrupted time signal reminiscent of the in vitro MRS time signal encoded in Ref. (22) at B 0  14.1 T (Larmor frequency, v L 5 600 MHz) from cancerous ovarian cyst fluid. Complex-valued zero-mean random Gaussian-distributed noise of level σ 5 0.1296 RMS is employed to corrupt the noiseless time signal. Here, RMS is root-mean-square of the noisefree time signal, which is built from the input parameters given in Table I . Partial signal length employed is N P 5 850, where N is the total length of the time signal (N 5 1024). Altogether 413 spurious resonances were generated in the entire Nyquist interval. Using a cut-off value d | | k −  0.001 for retaining the retrieved resonances, 28 spurious resonances are seen in the displayed frequency range. Reconstruction of spectral parameters and concentrations in FPT (2) : Noisy input data. Noise: σ 5 0.1296 RMS; Signal length: N P 5 850, N 5 1024.
procedure. Additional verification is afforded by varying the partial signal length and also by adding even further noise. Not only can one thereby identify genuine metabolites even if their amplitudes are extremely small, but it also becomes possible to distinguish these from spurious resonances. The final result of this binning process is that the most abundant, but unstable resonances are confidently discarded and all the true metabolic information is retained in the denoised spectrum.
It should be emphasized that this binning procedure through the FPT is entirely distinct from so-called "spectral editing" (42) whereby e.g. some overlapping resonances that are genuine, are artificially suppressed in order to better visualize metabolites of pre-defined interest. By such a "spectral editing" (41) , important information could easily be lost, since even low concentrations of certain metabolites that underlie larger resonances can be diagnostically relevant (43) . This is especially critical for MR-visible markers of malignant transformation. A case in point is phosphocholine (32) , a component of total choline, but which completely underlies the much more abundant phosphoethanolamine in the breast (29) . The FPT has been shown to identify and accurately quantify resonances that are completely overlapping (17, 18) , including phosphocholine and phosphoethanolamine in spectra as encoded from malignant and benign breast tissue (30, 31) .
Overall, for ideal, noiseless time signals, the FPT has been shown to achieve machine accuracy (17) . This constitutes the proof-of-principle, since the two adjacent frequencies separated by one part in 10 12 were unequivocally resolved as well as a total of some 25 resonances. Such a "superresolution" shows that the FPT is robust even against computational noise, since it retrieves the 12-digit input data with all 12-digits for every fundamental frequency and amplitude, with altogether 100 spectral parameters. However, more realistic signals always contain noise. Nevertheless, the FPT can still extract the complete physical information without any ambiguity (18) . This is made possible by the synergism of the said computational robustness and SNS, as also illustrated in the present study. Much higher noise levels that could completely mask small but still diagnostically important resonances could present a challenge to the straightforward application of the discussed convolution for generating the characteristic or secular polynomial Q K . In such cases, large noise corruption would heavily perturb extraction of the expansion coefficients {q s } for Q K . This, in turn, would also introduce large inaccuracies in the expansion coefficients {p r } of P K that are given in terms of {q s }.
We have tested the FPT in such applications and found that the best way to proceed is to avoid altogether solving the system of linear equations to obtain the set {q s }. Instead, the explicit analytical expressions for {p r } and {q s } should be used (15, 19) , since these produce stable spectra ± ± P Q / .
K K
Moreover, such a procedure yields accurate spectral parameters
, since rooting stable polynomials enables reliable extraction of fundamental parameters, as well as disentangling genuine from spurious resonances. It is in this way that the usual generation of Q K ± by convolution, as a limitation of the FPT and, indeed, the bottleneck of the Padé-based computations with FIDs heavily corrupted with noise, can be safely overcome. Promising as this might be, it should nevertheless be emphasized that overly noise-corrupted signals could be an indication of poorly performed measurement. This also underscores the need for taking all the necessary precautions (static magnetic field shimming, water and/or fat suppression by measurement, etc.) for encoding good quality time signals.
Implications of Padé-optimized MRS for Diagnostics Within Oncology
Firstly, MRS data must be acquired via experimental measurements, i.e. encoding. Secondly, these data are analyzed and finally clinical interpretation is carried out. Heretofore, we have emphasized the role of the FPT in data analysis, where the quantification problem is solved by decomposing the encoded data into its automatically classified true metabolic constituents. Ample evidence has been provided of the unique capability of the FPT in this regard (15, 16, 24, 30, 36) .
The potential role of Padé-optimization is, in fact, even broader. Data acquisition could be fundamentally revised based upon the high resolution capabilities of the FPT. Specifically, a much smaller number of short time signals would be needed to attain the needed levels of SNR. Padé-based optimization could also impact importantly upon clinical interpretation by expanding the diagnostic window, often detecting over 20 genuine metabolites for in vivo MRS, rather than a handful as obtained by Fourier analysis and fitting (44) . The ultimate goal of MRS is to reliably correlate the findings from quantification with the relevant diagnostic issues, particularly the eventual pathology of examined tissue. This is the added value in the name of enhanced diagnostic specificity by which MRS can uniquely complement the corresponding anatomical information from imaging modalities such as MRI. It is here that the FPT-guided MRS enhances overall performance with regard to the stated clinical aim of the examination.
Practical Advantages of the FPT with Respect to Data Acquisition: Shortened Scan Time with Good SNR
We will now focus our attention upon the implications of Padé-based optimization for data acquisition. It should first be recalled that within the FFT, a major obstacle has been low SNR. The fundamental limitation of the FFT is the inability to adequately analyze short time signals. Since MRS time signals decay exponentially, at longer acquisition times T mainly noise is recorded. The usual attempt to handle this conundrum has been to average a large number of time signals, usually about 200. The overall result is a long scan time, which is both impractical and costly. Yet this is the only way to attain acceptable SNR and still maintain reasonable accuracy when relying upon Fourier-based processing.
Since the FPT is not constrained by the requirement of a long total signal length N, good SNR can be achieved with a much smaller number of time signals, each of which is of much shorter duration T. As is illustrated in Figure 1 , at large truncations, the FFT generates only rough, distorted and completely uninterpretable spectra, whereas the FPT provides highly accurate spectra, and, moreover, achieves this objective with a very small number of time signal points. Varying the partial signal length N P for the same fixed bandwidth is equivalent to varying acquisition time T. Herein lies the practical advantage of the FPT in MRS by shortening both acquisition times of FIDs and the overall scanning time for the patient. Namely, by encoding shorter time signals with higher SNR, the number of signals needed is also diminished by as much as an order of magnitude. Thus, SNR is optimized by the FPT in conjunction with encoding time domain data in MRS. This is achieved by decreased repetition time (TR) and shorter time signals.
The FPT-provided feasibility of computing high-resolution spectra from encoded time signals using high truncation levels raises a key question as to whether or not MRS could be better served with a shorter TR, a low flip angle and a short readout time. This is diametrically opposite to the usual applications of MRS in the clinic by employing a long TR, a large flip angle and a long readout time, as demanded directly by the FFT. For example, FFT-guided MRS of the brain uses a slow, long sequence having conventional spectroscopy parameters such as TR of 2 seconds, flip angle of 90° and 2048 signal points sampled over a time interval of 500 milliseconds (ms). For the FPT, a fast, short TR sequence suffices with a truncation level of 4, as is a common occurrence with this processor, amounting to using only a quarter (512 data points) of full signal length N 5 2048 for the same fixed bandwidth. This would shorten acquisition time to 256 ms and allow short TR of 256 ms. Thus, this FPT-guided MRS sequence would permit 8 times as many signal acquisitions as the conventional FFT-based long TR sequence (45, 46) . With the mentioned high truncation level of the full time signal length, a significant gain in SNR becomes feasible with short TR spectroscopic sequences using the FPT to compute spectra from considerably shorter time signals. Further increase of SNR is achieved by performing multiple short TR acquisitions whose number is about 25 instead of 200 resulting in eightfold increased efficiency of the FPT relative to the conventional FFT approach.
Within the FPT, it is not only "signal averaging" but also "parameter averaging" which becomes possible. Therein, we can process independently e.g. all 25 encoded time signals and reconstruct 25 sets of spectral parameters for all true resonances. The final set of reconstructions is obtained by averaging these 25 sets of values of each parameter to generate standard deviations similar to the usual procedures with error bars obtained in typical measurements.
Possibilities for Improved Efficiency and Cost-effectiveness via Padé-optimized MRS
This strategy is of clear clinical relevance, above all, because of the improved diagnostic accuracy and reliability of MRS provided by the FPT. Shorter examination times would be a further advantage, resulting in shorter turn-around time for patients, improving the efficacy and cost-effectiveness of MRS. In contrast, the limitations of the FFT are directly due to the combination of a long readout length for each encoded time signal and multiple time signal acquisitions accompanied by averaging these FIDs, resulting in a long examination time. As noted, this latter obstacle is one of the principal reasons for the high cost of the MR procedure. Thus, the robust mathematical approach provided by the FPT yields not only precise quantification of MRS data, the ultimate goal of data analysis, but can also fundamentally change the way in which MRS time signals are encoded.
Potential Impact for Ovarian Cancer Detection
In the presence of higher noise levels, the FPT was shown in this paper to afford excellent resolution and to provide exact reconstructions of the metabolite concentrations of the genuine resonances, as seen in malignant ovarian cyst fluid by using the MRS input data associated with encoding form Ref. (22) . The far more numerous spurious resonances were effectively identified and binned/filtered out, to yield a "denoised" spectrum in the FPT. As stated, the FPT is capable of identifying and quantifying closely overlapping resonances, including phosphocholine, a marker of malignant transformation and a component of total choline. Recent attention has been given to the possible improvement in diagnostic yield of MRS for ovarian cancer by identifying the components of total choline, in particular phosphocholine (20) .
It has long been suggested that in vivo MRS could be the method of choice for early stage ovarian cancer detection, and that in order to achieve this goal, acquisition of highquality MRS time signals and the means to reliably analyze these measured data are needed (47). Together with the successful applications of the FPT to MRS data from other malignancies (16, 30, 31) , the results presented herein support pursuing the avenue of Padé-optimized MRS, which is foreseen to be an important step towards accurate and timely detection of ovarian cancer. Given that prognosis depends upon early detection of ovarian cancer (21, (48) (49) (50) , a major survival benefit for women afflicted with this malignancy is a key goal of this strategy.
Broader Implications for Oncology
Overall, better equipped mathematics via the FPT provide not only exact quantification of MRS data, but can also fundamentally alter the concept by which MR time signals are encoded. The parametric, high-resolution FPT has a paramount advantage in SNR over the non-parametric, low-resolution FFT. This is because the FPT needs only short time signals compared to conventional acquisitions using the FFT. For short time signals, the FFT gives uninterpretable spectra. By contrast, the encoding of short FIDs presupposes parametric signal processing such as that by means of the FPT. It is in this way that the FPT can directly influence the measurements by designing the manner in which time signals should be encoded to enhance the overall performance of MRS/MRSI in the future. Such advances are deemed to be of strategic importance for tumor diagnostics in general and, particularly for timely diagnosis of ovarian cancer, which would profoundly impact upon prognosis. This is reasoned by the fact that tumor first manifests itself on a molecular level where pathology can be detected much earlier than the subsequent disorders perceived on anatomical/morphological images. Therefore, FPT-based quantification together with the outlined Padéguided strategy for encoding MRS data, molecular imaging through magnetic resonance can become more reliable and cost-effective, with the potential for improved cancer diagnostics and treatment.
Conclusions and Perspectives
The potential power of magnetic resonance spectroscopy, or MRS, is hindered by a number of obstacles, such as:
1. Low reproducibility of findings, primarily due to subjectivity and non-uniqueness of all the existing signal processing approaches, based on the FFT, with fitting algorithms, 2. Low SNR, necessitating 3. A large number of acquisitions (to increase SNR), with the undesirable consequence of 4. Long scan time, yielding 5. Deterioration of the quality of metabolite final spectra, due to averaging of all the existing time signals encoded under unequal conditions (patient movement, physiological motion, etc.) and 6. High operational cost.
The limitations (2)-(6) are caused by restrictions inherent in (1) . Thus, the term "subjective" in (1) is associated with "input uncertainty" and refers to signal processors that exhibit user-dependent variability in choices of initialization for data analysis. Further, the term "non-uniqueness" in (1) is related to "output uncertainty" and points to data analytical methods whose results vary, with no indication of convergence/stabilization with changes in the number and starting values of spectral parameters. Examples of these "input" and "output uncertainties" can be found in all the "FFT 1 fitting" approaches within MRS, including the widely-used Linear Combination of Model in vitro Spectra (LCModel) from Ref. (51) . Thus, regarding the input uncertainties, no recommendation exists in e.g. the LCModel as to which metabolites of the simulated basis set should be included prior to the analysis of least-square adjustments to the given FFT spectrum from the averages of the encoded time signals. As such, different users choose different basis sets of metabolites for the studied Fourier spectrum associated with the measured time signals. This inevitably leads to overmodeling (prediction of false information) or undermodeling (missing true information), both with biased estimates of concentrations of the metabolites that are actually present in the scanned tissue. For example, the LCModel tries to cope with undermodeling/ underfitting due to an insufficient number of resonances in the preassigned basis set of metabolites by compensating for the missing peaks, while minimizing the least-square residuals. The net effect of the absence of some of the true resonances is in this way reflected in obtaining higher concentrations for the fewer preselected metabolites. Such outcomes are untenable, especially from the clinical perspective. Further, with respect to the other factors influencing "output uncertainties" in the LCModel, there is no consensus for the unique data set characterizing e.g. prior knowledge used as constraints to fitting. Prior knowledge is a notion which means "prior information" taken as being known about the sought spectral parameters and this is assumed to be inherent in the time signals yet to be encoded. For instance, in the LCModel and all other fitting techniques, ratios of peak heights of selected metabolites are often fixed to have certain given values prior to spectral analysis. The use of prior knowledge within fitting suffers from superficial attempts to mitigate wide and unphysical variations of reconstructions of spectral features by imposing ad hoc constraints to fitting. This is an ill-conceived procedure, since such preassigned conditions can force any fitting algorithm to artificially increase/decrease the estimations of the unknown true concentrations of metabolites. This leads to bias, exemplifying one of the "output uncertainties". One then inquires as to whether there could exist a signal processing methods which by lifting obstacle (1) would automatically also eliminate the remaining limitations (2)-(6), according to:
(I) Objectivity (no user-imposed subjective interventions, no data editing, using exclusively the raw FIDs directly from intact encoding) coupled with uniqueness (convergence of the results to the exact, unequivocal information inherent in the analyzed data), (II) High SNR (identification of noise and its subsequent reduction or elimination) implying (III) A small number of acquisitions that, in turn, would shorten patient scan time, thus yielding (IV) Improved quality of metabolite finite spectra (a smaller number of acquisitions under more similar conditions due to a much shorter time needed with the patient in the scanner), with the bonus of (V) Enhanced cost-effectiveness.
According to the present work, requirements (I)-(V) precisely coincide with the main operational characteristics of the FPT. Therefore, the FPT is qualified to be used to fill the gaps in previous applications of MRS for tumor diagnostics. The outcomes of a large number of studies have already been deemed promising for MRS merely by reliance upon a handful of metabolite concentrations estimated by various types of subjective and non-unique fitting of Fourier spectra. Such a severely restricted window can be greatly widened by Padé-processing, without any fitting to supply unbiased and objective, absolute concentrations of many metabolites, including their ratios, all accurately and reliably reconstructed from the raw, unedited MRS encodings with no use whatsoever of prior knowledge. The full information is already contained in the input, encoded time signal. Therefore, an adequate theoretical method based on the physics and biochemistry of the quantification problem in MRS does not need any supplementary information such as prior knowledge.
We can conclude that our initiative (15) to reformulate the quantification problem in MRS in terms of quantummechanical spectral analysis has expanded the horizons of signal processing. It has brought the predictive power of quantum physics to objectively and uniquely determine the automatically classified, true biochemical composition of the scanned tissue and to evaluate its functionality. This key information stems from the quantum-mechanical description of the time dynamics which predicts the precise mathematical forms for the time signal and its spectrum, both of which coincide with the corresponding expressions from the FPT. Widespread awareness and, indeed, consensus exists about the saturation of medical physics by empirical, phenomenological, data-driven fitting approaches. It is high time to inject the "fresh blood" of fundamental physics into this research discipline. The presently outlined strategy illustrates the practical benefit of such an initiative which is anticipated to improve the prospect of MRS becoming a part of the routine armamentarium in clinical oncology, especially for early tumor diagnostics.
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